Related references
Note: Only part of the references are listed.Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells
Raphael Benhamou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Small molecule recognition of disease-relevant RNA structures
Samantha M. Meyer et al.
CHEMICAL SOCIETY REVIEWS (2020)
Investigating the role of microRNA-27a gene polymorphisms and its interactive effect with risk factors in gastrointestinal cancers
Zioni Sangeetha Shankaran et al.
HELIYON (2020)
Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine
Matthew D. Disney
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression
Wei Zhao et al.
MOLECULAR MEDICINE REPORTS (2018)
Modulation of oncogenic miRNA biogenesis using functionalized polyamines
Cathy Staedel et al.
SCIENTIFIC REPORTS (2018)
miR-27a in serum acts as biomarker for prostate cancer detection and promotes cell proliferation by targeting Sprouty2
Weiyin Gao et al.
ONCOLOGY LETTERS (2018)
A Massively Parallel Selection of Small Molecule-RNA Motif Binding Partners Informs Design of an Antiviral from Sequence
Jessica L. Childs-Disney et al.
CHEM (2018)
miR-27a promotes human breast cancer cell migration by inducing EMT in a FBXW7-dependent manner
Guobin Jiang et al.
MOLECULAR MEDICINE REPORTS (2018)
Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays
Colleen M. Connelly et al.
ACS CHEMICAL BIOLOGY (2017)
In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway
Ling-Yu Kong et al.
ONCOTARGET (2017)
Defining RNA Small Molecule Affinity Landscapes Enables Design of a Small Molecule Inhibitor of an Oncogenic Noncoding RNA
Sai Pradeep Velagapudi et al.
ACS CENTRAL SCIENCE (2017)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer
Claire E. Fletcher et al.
HUMAN MOLECULAR GENETICS (2012)
MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
Wei Tang et al.
PLOS ONE (2012)
MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
Mikael Lerner et al.
CELL CYCLE (2011)
Rational Design of Ligands Targeting Triplet Repeating Transcripts That Cause RNA Dominant Disease: Application to Myotonic Muscular Dystrophy Type 1 and Spinocerebellar Ataxia Type 3
Alexei Pushechnikov et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells
Susanne U. Mertens-Talcott et al.
CANCER RESEARCH (2007)
miRBase: microRNA sequences, targets and gene nomenclature
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2006)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
A uniform system for microRNA annotation
V Ambros et al.
RNA (2003)
Share Paper
